FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026505154> ?p ?o ?g. }

• W3026505154 endingPage "827" @default.
• W3026505154 startingPage "823" @default.
• W3026505154 abstract "Objectives Nusinersen (Spinraza®, Biogen) and onasemnogene abeparvosec (Zolgensma®, Novartis) are novel gene-based therapies for the orphan disease Spinal Muscular Atrophy. Onasemnogene abeparvosec has been allocated an acquisition cost of up to US$5 million per patient. We undertook a rapid inquiry to evaluate if onasemnogene abeparvosec is likely to be cost-effective for the UK NHS.Methods We used publicly available cost-effectiveness data and recommended methodology to perform cost-utility evaluation of onasemnogene abeparvosec versus best supportive care and nusinersen.Results Our evaluations highlight wide variations in cost and benefit estimates of nusinersen and indicate that onasemnogene abeparvosec is unlikely to represent value for money according to current standards of reimbursement. Results are discussed in the context of reimbursement decisions for orphan diseases.Conclusion Commonly implemented commercial confidentiality practices combined with uncertain data obscure scrutiny and justification of past and present reimbursement decisions for orphan drugs. Future cutting edge expensive therapies will be numerous, they will entail very substantial economic strains. We conclude that there is an urgent and increasing need for the development of improved procedures that can lead to equitable, consistent, and transparent decision-making." @default.
• W3026505154 created "2020-05-29" @default.
• W3026505154 creator A5024923244 @default.
• W3026505154 creator A5033450071 @default.
• W3026505154 creator A5062740772 @default.
• W3026505154 creator A5088300557 @default.
• W3026505154 creator A5090784666 @default.
• W3026505154 date "2020-06-11" @default.
• W3026505154 modified "2023-10-14" @default.
• W3026505154 title "Will the US$5 million onasemnogene abeparvosec treatment for spinal muscular atrophy represent ‘value for money’ for the NHS? A rapid inquiry into suggestions that it may be cost-effective" @default.
• W3026505154 cites W1588354054 @default.
• W3026505154 cites W1593719663 @default.
• W3026505154 cites W2038630766 @default.
• W3026505154 cites W2048941620 @default.
• W3026505154 cites W2065306083 @default.
• W3026505154 cites W2101315195 @default.
• W3026505154 cites W2105845113 @default.
• W3026505154 cites W2119820612 @default.
• W3026505154 cites W2145413800 @default.
• W3026505154 cites W2165663095 @default.
• W3026505154 cites W2409536194 @default.
• W3026505154 cites W2522595009 @default.
• W3026505154 cites W2563045737 @default.
• W3026505154 cites W2564421461 @default.
• W3026505154 cites W2565041597 @default.
• W3026505154 cites W2733659072 @default.
• W3026505154 cites W2749046994 @default.
• W3026505154 cites W2750790091 @default.
• W3026505154 cites W2768885431 @default.
• W3026505154 cites W2769295220 @default.
• W3026505154 cites W2770254801 @default.
• W3026505154 cites W2774185088 @default.
• W3026505154 cites W2798147159 @default.
• W3026505154 cites W2913601304 @default.
• W3026505154 cites W2925121506 @default.
• W3026505154 cites W2944757191 @default.
• W3026505154 cites W2981894497 @default.
• W3026505154 cites W2983706326 @default.
• W3026505154 cites W3002862034 @default.
• W3026505154 doi "https://doi.org/10.1080/14712598.2020.1772747" @default.
• W3026505154 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32434404" @default.
• W3026505154 hasPublicationYear "2020" @default.
• W3026505154 type Work @default.
• W3026505154 sameAs 3026505154 @default.
• W3026505154 citedByCount "9" @default.
• W3026505154 countsByYear W30265051542020 @default.
• W3026505154 countsByYear W30265051542021 @default.
• W3026505154 countsByYear W30265051542022 @default.
• W3026505154 countsByYear W30265051542023 @default.
• W3026505154 crossrefType "journal-article" @default.
• W3026505154 hasAuthorship W3026505154A5024923244 @default.
• W3026505154 hasAuthorship W3026505154A5033450071 @default.
• W3026505154 hasAuthorship W3026505154A5062740772 @default.
• W3026505154 hasAuthorship W3026505154A5088300557 @default.
• W3026505154 hasAuthorship W3026505154A5090784666 @default.
• W3026505154 hasBestOaLocation W30265051544 @default.
• W3026505154 hasConcept C112930515 @default.
• W3026505154 hasConcept C119857082 @default.
• W3026505154 hasConcept C144133560 @default.
• W3026505154 hasConcept C151730666 @default.
• W3026505154 hasConcept C160735492 @default.
• W3026505154 hasConcept C162118730 @default.
• W3026505154 hasConcept C162324750 @default.
• W3026505154 hasConcept C17744445 @default.
• W3026505154 hasConcept C177713679 @default.
• W3026505154 hasConcept C199539241 @default.
• W3026505154 hasConcept C2776050585 @default.
• W3026505154 hasConcept C2776291640 @default.
• W3026505154 hasConcept C2779343474 @default.
• W3026505154 hasConcept C2779703844 @default.
• W3026505154 hasConcept C3019080777 @default.
• W3026505154 hasConcept C38652104 @default.
• W3026505154 hasConcept C41008148 @default.
• W3026505154 hasConcept C50522688 @default.
• W3026505154 hasConcept C60644358 @default.
• W3026505154 hasConcept C71745522 @default.
• W3026505154 hasConcept C71924100 @default.
• W3026505154 hasConcept C75480439 @default.
• W3026505154 hasConcept C86803240 @default.
• W3026505154 hasConceptScore W3026505154C112930515 @default.
• W3026505154 hasConceptScore W3026505154C119857082 @default.
• W3026505154 hasConceptScore W3026505154C144133560 @default.
• W3026505154 hasConceptScore W3026505154C151730666 @default.
• W3026505154 hasConceptScore W3026505154C160735492 @default.
• W3026505154 hasConceptScore W3026505154C162118730 @default.
• W3026505154 hasConceptScore W3026505154C162324750 @default.
• W3026505154 hasConceptScore W3026505154C17744445 @default.
• W3026505154 hasConceptScore W3026505154C177713679 @default.
• W3026505154 hasConceptScore W3026505154C199539241 @default.
• W3026505154 hasConceptScore W3026505154C2776050585 @default.
• W3026505154 hasConceptScore W3026505154C2776291640 @default.
• W3026505154 hasConceptScore W3026505154C2779343474 @default.
• W3026505154 hasConceptScore W3026505154C2779703844 @default.
• W3026505154 hasConceptScore W3026505154C3019080777 @default.
• W3026505154 hasConceptScore W3026505154C38652104 @default.
• W3026505154 hasConceptScore W3026505154C41008148 @default.
• W3026505154 hasConceptScore W3026505154C50522688 @default.
• W3026505154 hasConceptScore W3026505154C60644358 @default.

• next